MedPath

Metyrosine

Generic Name
Metyrosine
Brand Names
Demser
Drug Type
Small Molecule
Chemical Formula
C10H13NO3
CAS Number
672-87-7
Unique Ingredient Identifier
DOQ0J0TPF7

Overview

An inhibitor of the enzyme tyrosine 3-monooxygenase, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with pheochromocytoma. (Martindale, The Extra Pharmacopoeia, 30th ed)

Background

An inhibitor of the enzyme tyrosine 3-monooxygenase, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with pheochromocytoma. (Martindale, The Extra Pharmacopoeia, 30th ed)

Indication

For use in the treatment of patients with pheochromocytoma, for preoperative preparation of patients for surgery, management of patients when surgery is contraindicated, and chronic treatment of patients with malignant pheochromocytoma.

Associated Conditions

  • Pheochromocytoma

FDA Approved Products

metyrosine
Manufacturer:Amneal Pharmaceuticals NY LLC
Route:ORAL
Strength:250 mg in 1 1
Approved: 2023/01/11
NDC:69238-1621
Metyrosine
Manufacturer:Oceanside Pharmaceuticals
Route:ORAL
Strength:250 mg in 1 1
Approved: 2021/07/01
NDC:68682-310
metyrosine
Manufacturer:Amneal Pharmaceuticals NY LLC
Route:ORAL
Strength:250 mg in 1 1
Approved: 2020/07/28
NDC:60219-1621
Demser
Manufacturer:Bausch Health US, LLC
Route:ORAL
Strength:250 mg in 1 1
Approved: 2021/07/01
NDC:25010-305

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath